RobinAMeolaAMunioMGollionCFabryV. Recurrent stroke and peripheral neuropathy associated with multifactorial hyperhomocysteinemia: a case report. Neurohospitalist. 2026;16:207-210.
2.
AmarencoPBogousslavskyJCaplanLRDonnanGAWolfMEHennericiMG. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1-5.
3.
DaghlasIWangMGillD. Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations. Thromb J. 2025;23(1):1-5.
4.
BostomAGRosenbergIHSilbershatzH, et al.Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med. 1999;131(5):352-355.
5.
ParnettiLCasoVSantucciA, et al.Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci. 2004;25(1):13-17.
6.
MeschiaJFBushnellCBoden-AlbalaB, et al.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832.
